Web Directory NeuroGeneration: Neural Stem Cell Therapies Biotechnology for Parkinson's Disease, Alzheimer's Disease, Epilepsy, Spinal Cord injury, Stroke and MS/ALS
  Contact UsLinksSite Map  
 
About NeuroGenerationWhat is Stem Cell Therapy?Clinical DevelopmentNews & EventsInvestors
 
   
 

NeuroGeneration is a biotherapeutics company that develops new treatments and products for patients with neurological diseases, including Parkinson's Disease, Alzheimer's Disease, Epilepsy, Spinal Cord injury, Stroke and MS/ALS.
News & Events

March 1, 2010

US Patent issued to NeuroGeneration. The USPTO has issued a key patent for NeuroGeneration's ....read more: PRESS RELEASE

February 16, 2009

Grounbreaking paper publishes long term results of a successful Phase I Clinical Trial .. more>

October 15, 2008

NeuroGeneration named as one of 27 industry trendsetters for 2009 in Stem Cell Approaches in Neurology and Psychiatry Today ... more>
Clinical Trials

NeuroGeneration has been authorized by the FDA to conduct a phase II clinical trial for Parkinson's disease. This trial is currently on hold until we complete our cGMP processing center.